Web Results

Shire Sues Neos To Block Adderall XR Competitor - Law360


Apr 12, 2013 ... The case is Shire LLC v. Neos Therapeutics, Inc., case number 3:13-cv-01452, in the U.S. District Court for the Northern District of Texas.

Neos Therapeutics Announces Settlement Of Pending Patent ...


Sep 9, 2014 ... DALLAS & FORT WORTH, Texas----Neos Therapeutics, Inc. , a specialty ... Its Amphetamine Polistirex XR-ODT (NT-0202) With Shire LLC ...



SHIRE LLC v. AMERIGEN PHARMACEUTICALS LIMITED. 1:14-cv-06095; Filed: 10/01/2014; Case Updated Daily; Latest Docket Entry: 08/17/2016; PACER.

Orange Book: Approved Drug Products with Therapeutic ... - FDA


Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Share · Tweet ... Search by Applicant (Company). OR. Select one or more ...

The Efficacy and Safety of Evekeo, Racemic Amphetamine Sulfate ...


The average difference between treatments (R-AMPH vs. placebo) was estimated ..... Shionogi Pharma, and Shire Pharmaceuticals; a speaker and research support ... Neos Therapeutics, and Rhodes Pharmaceuticals; and a research support for .... Psychopharmacology are provided here courtesy of Mary Ann Liebert, Inc.

Pharmaceutical Company Directory - Drugs.com


Browse all medications: a b c d e f g h i j k l m n o p q r s t u v w x y z ... Information includes company addresses, telephone numbers, stock quotes, links to corporate websites, ... Search the Pharmaceutical Company Database ... Napo Pharmaceuticals, Inc.Neos Therapeutics, Inc.Neurocrine Biosciences, Inc. NeurogesX, ...

MPH XR-ODT - Clinical Trial Centers


This study was funded by Neos Therapeutics, Inc (Grand Prairie, TX). ... Editorial support was provided by Liqing Xiao, PhD, of AlphaBioCom, LLC (King of Prussia, PA). ... Dr. Ann Childress reports consultant relationships with Shire, Novartis, Pfizer, ..... vs placebo: 75.7 [67.0, 84.4]; p <0.0001) on the classroom study day.

Single-Dose Pharmacokinetics of Methylphenidate Extended ... - NCBI


... or Sprinkles Versus Methylphenidate Immediate-Release Tablets (Ritalin<sup>®</sup>) in ..... Enzymotec, GencoSciences LLC, Lupin, Neurovance, Sunovion, and Shire. ... Eli Lilly, Ironshore, Neos Therapeutics Inc., NextWave Pharmaceuticals, Noven, ...

Extended-release guanfacine hydrochloride in 6–17-year olds with ...


Feb 12, 2016 ... TTF was significantly longer in GXR versus placebo (p = 0.003). ...... The study was sponsored by Shire Development, LLC. ... Ironshore, Lupin, Neos, Neurovance, NFL, Rhodes and Shire, and a member of the DSMB for Sunovion. ..... Copyright © 1999 - 2016 John Wiley & Sons, Inc. All Rights Reserved.

Full Text HTML - Mary Ann Liebert, Inc. publishers


Oct 6, 2014 ... <sup>3</sup>Shire Development LLC, Wayne, Pennsylvania. ... of the time of GXR administration (p<0.001 vs. placebo for GXR a.m. and GXR p.m.). ..... Diagnostics, Enzymotec, GencoSciences, Neos Therapeutics, Shire, and Sunovion.

More Info

(NT-0202) with Shire LLC - Neos Therapeutics


Sep 9, 2014 ... Neos Therapeutics, Inc. Announces Settlement of Pending Patent Litigation Concerning its Amphetamine Polistirex XR-ODT (NT-0202) with ...

Blue Bell firm wins approval for unique ADHD treatment - Philly.com


Jan 28, 2016 ... Neos Therapeutics Inc. secured final FDA approval late Wednesday for ... Adzenys XR-ODT will compete with Shire's Adderall and Vyvanse and ... to take medicine that dissolves on the tongue "vs. a pill or capsule. .... Copyright 2016 Philadelphia Media Network (Digital), LLC Terms of Use & Privacy Policy.

Gregg Gentile | LinkedIn


Current. G. Alan & Associates, LLC,; Pierce Township Board of Zoning Appeals ... Shire Pharmaceuticals ... Head of ADHD Marketing at Neos Therapeutics, Inc.